Pancreatic Islet Cell Carcinoma

Also known as: Malignant neoplasm of islets of Langerhans / Carcinoma, Islet Cell / Islet Cell Carcinoma / Malignant neoplasm of endocrine pancreas / Malignant pancreatic islet neoplasm / Pancreatic islet cell neoplasm malignant NOS / Islet cell carcinoma (morphologic abnormality) / Malignant tumor of Islets of Langerhans (disorder) / Carcinoma of endocrine pancreas (disorder) / Primary malignant neoplasm of islets of langerhans (disorder)

DrugDrug NameDrug Description
DrugDrug NameTargetType
DrugDrug NamePhaseStatusCount
DB11702Antineoplaston A102Withdrawn1
DB01101Capecitabine2Active Not Recruiting1
DB01590Everolimus2Completed2
DB00099Filgrastim2Terminated1
DB00104Octreotide2Completed2
DB00104Octreotide2Withdrawn1
DB00853Temozolomide2Active Not Recruiting1
DB04879Vatalanib2Withdrawn1
DB01268Sunitinib3Terminated1
DB01268SunitinibNot AvailableCompleted1